L3harris Technologies Earnings Calls
| Release date | Jul 24, 2026 |
| EPS estimate | 2.45€ |
| EPS actual | - |
| Revenue estimate | 5.072B |
| Revenue actual | - |
| Expected change | +/- 2.68% |
| Release date | Apr 30, 2026 |
| EPS estimate | 2.19€ |
| EPS actual | 2.35€ |
| EPS Surprise | 7.31% |
| Revenue estimate | 4.688B |
| Revenue actual | 4.972B |
| Revenue Surprise | 6.05% |
| Release date | Jan 29, 2026 |
| EPS estimate | 2.35€ |
| EPS actual | 2.44€ |
| EPS Surprise | 3.83% |
| Revenue estimate | 4.913B |
| Revenue actual | 4.809B |
| Revenue Surprise | -2.12% |
| Release date | Oct 30, 2025 |
| EPS estimate | 2.20€ |
| EPS actual | 2.10€ |
| EPS Surprise | -4.55% |
| Revenue estimate | 5.759B |
| Revenue actual | 4.832B |
| Revenue Surprise | -16.10% |
Last 4 Quarters for L3harris Technologies
Below you can see how HRS.DE performed 4 days prior and 4 days after releasing the earnings report. Also, you can see the pre-estimates and the actual earnings. This information can give you a slight idea of what you might expect for the next quarter's release.
| Release date | Oct 30, 2025 |
| Price on release | 261.40€ |
| EPS estimate | 2.20€ |
| EPS actual | 2.10€ |
| EPS surprise | -4.55% |
| Date | Price |
|---|---|
| Oct 24, 2025 | 252.60€ |
| Oct 27, 2025 | 250.40€ |
| Oct 28, 2025 | 248.80€ |
| Oct 29, 2025 | 248.10€ |
| Oct 30, 2025 | 261.40€ |
| Oct 31, 2025 | 261.40€ |
| Nov 03, 2025 | 249.60€ |
| Nov 04, 2025 | 252.80€ |
| Nov 05, 2025 | 252.00€ |
| 4 days before | 3.48% |
| 4 days after | -3.60% |
| On release day | 0% |
| Change in period | -0.238% |
| Release date | Jan 29, 2026 |
| Price on release | 296.60€ |
| EPS estimate | 2.35€ |
| EPS actual | 2.44€ |
| EPS surprise | 3.83% |
| Date | Price |
|---|---|
| Jan 23, 2026 | 302.80€ |
| Jan 26, 2026 | 297.30€ |
| Jan 27, 2026 | 301.00€ |
| Jan 28, 2026 | 301.50€ |
| Jan 29, 2026 | 296.60€ |
| Jan 30, 2026 | 288.10€ |
| Feb 02, 2026 | 286.60€ |
| Feb 03, 2026 | 293.80€ |
| Feb 04, 2026 | 288.90€ |
| 4 days before | -2.05% |
| 4 days after | -2.60% |
| On release day | -2.87% |
| Change in period | -4.59% |
| Release date | Apr 30, 2026 |
| Price on release | 270.10€ |
| EPS estimate | 2.19€ |
| EPS actual | 2.35€ |
| EPS surprise | 7.31% |
| Date | Price |
|---|---|
| Apr 24, 2026 | 273.10€ |
| Apr 27, 2026 | 273.50€ |
| Apr 28, 2026 | 276.30€ |
| Apr 29, 2026 | 273.90€ |
| Apr 30, 2026 | 270.10€ |
| May 04, 2026 | 266.00€ |
| May 05, 2026 | 259.90€ |
| May 06, 2026 | 256.50€ |
| May 07, 2026 | 256.60€ |
| 4 days before | -1.10% |
| 4 days after | -5.00% |
| On release day | -1.52% |
| Change in period | -6.04% |
| Release date | Jul 24, 2026 |
| Price on release | - |
| EPS estimate | 2.45€ |
| EPS actual | - |
| Date | Price |
|---|---|
| Jun 29, 2026 | 251.90€ |
| Jun 30, 2026 | 253.10€ |
| Jul 01, 2026 | 258.10€ |
| Jul 02, 2026 | 262.90€ |
| Jul 03, 2026 | 264.10€ |
L3harris Technologies Earnings Call Transcript Summary of Q1 2026
L3Harris reported a strong Q1 2026: revenue of $5.7B (≈15% organic growth), segment operating income of $902M, and GAAP EPS of $2.72 (up 33% YoY). The company emphasized record backlog (nearly doubled to >$40B) plus ~ $25B of pending Munitions Acceleration Council (MAC) orders under negotiation. Key commercial wins included a >$2.2B international missionized business-jet program (initial $726M booked), ~ $700M in Canadian tanker/transport contracts, $460M of international resilient communications orders, and continued SDA/space tracking momentum (56 SDA tracking satellites to date; HBTSS follow-on proposal submitted). Management highlighted strategic actions: filing an S-1 to IPO the Missile Solutions business (new name: AXYV), receiving a $1B Department of War investment to accelerate solid rocket motor capacity, and agreeing to sell 60% of the Space Propulsion & Power Systems business. Financial outlook was reaffirmed: FY 2026 revenue $23.0–23.5B (≈7% organic growth at midpoint), segment operating margin low-16%, free cash flow guidance $3B (back-half weighted), and GAAP EPS raised $0.10 to $11.40–$11.60. Short-term free cash flow was negative ($187M) due to working capital timing—management characterized this as typical for Q1. Key investor considerations: substantial backlog and MAC upside provide durable multi-year revenue visibility, aggressive capacity and supply-chain investments (supported by DoW funding) reduce downside production risk, but timing/definitization of MAC frameworks and contract flows, working-capital seasonality, and classified program concentration remain drivers of near-term outcome variability.
Sign In
Buy HRS